CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,170 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001404
NCT00001404N/ACompleted

Genetic and Clinical Studies of Congenital Anomaly Syndromes

National Human Genome Research Institute (NHGRI)·observational·Posted Nov 4, 1999·Updated Dec 16, 2019

In Brief

An observational study for Malformations and 2 related conditions. Completed, enrolled 1,170 participants across 4 sites in 2 countries.

Detailed Summary

We aim to delineate the range of severity, natural history, molecular etiology, and pathophysiology of Pallister-Hall syndrome (PHS), Greig cephalopolysyndactyly syndrome (GCPS), McKusick-Kaufman syndrome (MKS), Bardet-Biedl syndrome (BBS), Oro-facial digital syndromes (OFDs), and other overlapping phenotypes. These disorders comprise a syndrome community of overlapping manifestations and we hypothesize that this is a reflection of a common mechanistic pathway. This hypothesis be addressed by a combined clinical-molecular approach where we bring up to 50-100 patients with each disorder to the NIH clinical center for a comprehensive clinical evaluation with follow-up at a frequency appropriate to the disorder. Specimens will be collected and evaluated in the laboratory by linkage analysis, physical mapping, candidate gene characterization, mutation screening, and cell biologic studies of normal mutant proteins.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye), United States
Collaborators--

Timeline

N/ACompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartAug 18, 1994
Study CompletionJan 7, 2016
TodayJul 2, 2026
Posted 26.7 years ago